Illustration of diabetic macular ischemia, showing capillary loss in the central retina of a diabetic eye.

Macular ischemia is a loss of blood flow in the capillaries of the macula, the central part of the retina that gives sharp, colorful vision. Diabetes is the most common cause, so most patients meet it as diabetic macular ischemia. The damage is permanent, no approved treatment restores it, and the best strategy is early detection with strict control of systemic risk factors.

What is macular ischemia?

The macula is the small central area of the retina responsible for reading, recognizing faces and seeing color. Its photoreceptors work hard and depend on a steady oxygen supply from the capillaries that surround the fovea. When those capillaries close, the tissue starves and central vision declines.

At the center of the macula lies the foveal avascular zone (FAZ), a capillary-free area ringed by a fine vascular network. In macular ischemia the FAZ enlarges and its border becomes irregular. You will also see the terms ischemic maculopathy, ischaemic maculopathy and macular ischaemia (British spelling) for the same problem.

How diabetes causes diabetic macular ischemia

Diabetic macular ischemia is reduced perfusion of the macula caused by chronic hyperglycemia. Sustained high blood glucose injures the retinal microvessels and produces either leakage or occlusion of capillaries and precapillary arterioles. Both processes can occur in the same eye.

Leakage of retinal capillaries

Retinal capillaries are lined by a single layer of endothelium wrapped by pericytes, the supporting cells that help control what passes out of the blood. Hyperglycemia destroys pericytes and weakens the junctions between endothelial cells. The wall becomes abnormally permeable, which produces microaneurysms, hard exudates, hemorrhages and retinal edema.

Occlusion of retinal capillaries

High glucose also thickens the capillary basement membrane. The vessels first narrow and then close completely, so blood no longer reaches the inner retina and the macula loses oxygen and nutrients. This capillary dropout is a complication of diabetic retinopathy, and it usually begins around the fovea.

Capillaries that have dropped out do not grow back. That is why the vision loss from macular ischemia is irreversible, even when the eye is otherwise treated well.

Test your knowledge 8 questions from this article
Choroida · Fundus imaging

Fundus Explorer Pro

Photograph the retinal findings described here with the phone already in your pocket — 22 D optics and built-in illumination in one handheld unit.

From Choroida — the team behind this site

Retinal ischemia, ischaemic retinopathy and macular infarction: how the terms relate

Retinal ischemia is the broad term for inadequate blood supply to any part of the retina. Ischaemic retinopathy describes the retinal damage that follows, as seen in diabetic retinopathy, retinal vein occlusion and sickle cell retinopathy. Macular ischemia is the form that involves the central retina.

Macular infarction refers to sudden, severe capillary closure at the macula, with retinal whitening early on and thinning later. When the central retinal artery is blocked, the whole retina is ischemic and the fovea stands out as a cherry red spot.

Symptoms of macular ischemia

Many patients notice nothing early on. When symptoms appear, vision declines gradually, often with blur, a dim or blind spot in the center, and weaker contrast and color perception. Because the loss is slow, an eye can have extensive nonperfusion before the patient complains.

Visual acuity can stay acceptable until capillary loss reaches the central fovea. A normal Snellen chart therefore does not exclude macular ischemia, and imaging is needed to judge the macular circulation.

Diabetic Macular ischemia

Macular ischemia on FFA

Fluorescein angiography (FFA or FA) was the classic test for macular ischemia. It shows an enlarged, irregular FAZ with a broken perifoveal capillary ring, and dark patches of capillary dropout around the fovea. These are the features graders look for when staging ischemia.

FFA has limits. Dye leakage from macular edema can hide the capillaries underneath, and the injection can cause nausea and, rarely, allergic reactions. The study also shows mainly the superficial capillary layer, so deeper damage is easy to miss.

Macular ischemia on OCT and OCTA

OCT angiography (OCTA) shows the retinal capillary layers without any dye injection, and it has become the preferred way to image macular ischemia. It displays the superficial and deep capillary plexuses separately, measures FAZ area and maps vessel density. The deep plexus is often affected as well, sometimes more severely.

Structural OCT adds supporting signs. Thinning of the inner retina, especially temporal to the fovea, points to ischemic damage, and disorganization of the retinal inner layers suggests a poorer visual outlook. OCT measurements can also help quantify ischemia in a repeatable way.

Interpret OCTA with care. Macular edema, motion, media opacity and segmentation errors can create false areas of nonperfusion, so always read the angiogram alongside the structural scan.

Other causes of retinal and macular ischemia

Diabetes is the leading cause, but the same picture of capillary dropout occurs in other conditions. When a patient has macular ischemia without a clear diabetic background, look for these:

  • Retinal vein occlusion, especially branch and central occlusions with extensive nonperfusion
  • Retinal artery occlusion, including paracentral acute middle maculopathy
  • Sickle cell retinopathy
  • Hypertensive retinopathy
  • Radiation retinopathy
  • Retinal vasculitis and systemic lupus erythematosus

Another diabetic complication, diabetic papillopathy, can also lower vision but causes optic disc swelling rather than macular capillary loss.

Macular ischemia treatment

No proven treatment restores perfusion in macular ischemia. Lost capillaries do not regenerate, so the aim is to protect the remaining retina and treat the coexisting disease. Managing risk factors can slow progression and reduce the chance of new ischemia.

Anti-VEGF injections and intravitreal steroids treat diabetic macular edema, but neither has shown meaningful reversal of capillary nonperfusion. Laser photocoagulation treats proliferative retinopathy and some forms of macular edema. It does not reverse macular ischemia and carries risks such as scotomas and visual field loss.

Systemic care carries the most weight. Aim for steady glycemic control, treat high blood pressure and lipids, and encourage smoking cessation. In type 2 diabetes, fenofibrate has been shown to slow diabetic retinopathy progression, so discuss it with the patient’s physician. Drugs aimed at reperfusion or neuroprotection remain under study.

Diabetic Macular ischemia

Risk factors for diabetic macular ischemia

High blood glucose and high blood pressure are the main contributing risk factors. Others increase the likelihood further:

  • Long duration of diabetes
  • Poor glycemic control over time
  • Moderate to severe diabetic retinopathy
  • Dyslipidemia and smoking
  • Diabetic kidney disease
All-fit smartphone adapter on a slit lampFundus Explorer Pro smartphone fundus camera
Choroida · Clinical imaging

Document what you see

Two smartphone imaging tools built for everyday clinic use — one for the slit lamp, one for the fundus.

From Choroida — the team behind this site

Monitoring and when to see an eye doctor

Because early macular ischemia is silent, patients with diabetes need regular dilated eye examinations. Adults with type 2 diabetes should be examined at diagnosis and then usually every year, and those with type 1 diabetes should begin within five years of diagnosis. Pregnancy calls for closer follow-up.

See an eye doctor promptly if your glucose or blood pressure runs persistently high, or if you notice blur, a central dark spot or any sudden change in vision. A detailed fundus examination with OCT or OCTA can find ischemia early, and follow-up visits show whether it is progressing.

Prognosis depends on how much of the central macula has lost its capillaries. Many eyes remain stable for long periods once systemic risk factors are controlled, but any vision already lost is permanent. Patients with reduced central vision benefit from low vision services and magnification aids.

Test yourself

A few questions straight from this article.

1 / 8 0 correct
  1. What is diabetic macular ischaemia?

Ahmed Ophthalmologist

Writes and reviews the clinical articles on Educate. Every post is checked against peer-reviewed sources before it goes live.